Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/43435
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis - caution with trough concentrations |
Author: | Coulthard, K. Peckham, D. Conway, S. Smith, C. Bell, J. Turnidge, J. |
Citation: | Journal of Cystic Fibrosis, 2007; 6(2):125-130 |
Publisher: | Elsevier BV |
Issue Date: | 2007 |
ISSN: | 1569-1993 1873-5010 |
Statement of Responsibility: | Kingsley P. Coulthard, Daniel G. Peckham, Steven P. Conway, Carol A. Smith, Jan Bell and John Turnidge |
Abstract: | <h4>Background</h4>: Once daily intravenous aminoglycoside dosing (ODD) is widely used to treat acute Pseudomonas aeruginosa exacerbations in patients with cystic fibrosis. Controversy exists as to what is the most appropriate method of therapeutic drug monitoring (TDM) of such therapy with recommendations including trough plasma concentrations of <1 mg/L or <2 mg/L, area under curve (AUC) and various nomograms. This study aimed to compare the exposures to ODD of tobramycin in adults and children with cystic fibrosis using the AUC and trough TDM approaches.<h4>Methods</h4>: Using a mono-exponential software program to calculate AUC from 2 plasma concentrations, AUCs were determined in 22 adults with pre-dose tobramycin concentrations <1 mg/L. The exposure of 5 children with reduced tobramycin clearances was simulated at the usual recommended dose of 10 mg/kg/daily but retaining a trough <1 mg/L.<h4>Results</h4>: A tobramycin dose of 10 mg/kg of tobramycin in these patients with normal serum creatinine and a trough concentration <1 mg/L resulted in exposures in excess of those associated with conventional 8-hourly dosing.<h4>Conclusions</h4>: The TDM approach of a trough <1 mg/L, as used with conventional 8-hourly tobramycin dosing, is not relevant to ODD. |
Keywords: | Sputum Humans Pseudomonas Infections Cystic Fibrosis Tobramycin Anti-Bacterial Agents Drug Monitoring Infusions, Intravenous Injections, Intravenous Drug Administration Schedule Area Under Curve Adolescent Adult Child Female Male |
Description: | Copyright © 2006 European Cystic Fibrosis Society Published by Elsevier B.V. |
DOI: | 10.1016/j.jcf.2006.05.015 |
Description (link): | http://www.elsevier.com/wps/find/journaldescription.cws_home/622283/description#description |
Published version: | http://dx.doi.org/10.1016/j.jcf.2006.05.015 |
Appears in Collections: | Aurora harvest 6 Pathology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.